Identification, Evaluation, and Management of High-Risk Disease in Early R/R MM

Aimee Merino, MD, discusses how the identification, evaluation, and management of high-risk disease in early relapsed/refractory multiple myeloma (R/R MM) involves prioritizing specific risk factors, distinguishing functional high-risk patients from those with standard risk, and tailoring treatment strategies accordingly.

EP: 1.A 60-Year-Old Man With Early Relapse Multiple Myeloma

Now Viewing

EP: 2.Identification, Evaluation, and Management of High-Risk Disease in Early R/R MM

Video content above is prompted by the following:

1. Let’s discuss the identification, evaluation, and management of high-risk disease in early R/R MM. What characteristics distinguish those patients from others?

• What factors do you prioritize when assessing high-risk disease?
• How do you define and approach treatment for standard risk patients (ie, HRCAs) vs those who are functional high-risk?

Recent Videos